Fig. 1 · Structure

Documents & Downloads

Varzutamig

Bispecific Antibody

Varzutamig is a bispecific antibody designed to simultaneously target CD3E and EGFR while being conjugated to albumin. This dual-targeting mechanism enhances T-cell activation and tumor cell cytotoxicity, making it a valuable tool in cancer immunotherapy research. Varzutamig is applicable in studies aimed at understanding T-cell mediated immune responses and developing novel therapeutic strategies for various malignancies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 3064817-31-5
Applications Bispecific Antibody

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...